Health
MS lifeline as drug that can slow disease listed – Chinchilla News
Patients who develop the second progressive stage of Multiple Sclerosis will only have to pay $41 for a drug that helps slow down the disease.
Patients living with multiple sclerosis have been granted a lifeline with the federal government listing a drug that can help slow down the progression of the disease.
The move will mean all patients who might benefit from “Mayzent” will only have to pay $41 per script rather than the estimated $25,000 yearly cost.
Multiple sclerosis, known as MS, is the most commonly acquired neurological disease in younger adults with more than 25,600 Australians living with the condition.
The average age of diagnosis…
-
Noosa News18 hours agoFearless tradie armed with hunting knife confronts teenage intruder at Mackay home
-
Business19 hours agoHow much could $10,000 in REA Group shares be worth in a year?
-
Noosa News15 hours agoGold Coast turns Hollywood for Chris Hemsworth film shoot
-
Noosa News18 hours agoTeen killer sentenced to 16 years’ imprisonment